Dianthus Therapeutics, Inc. (DNTH) Ownership

$18.43

$0.07 (0.35%)
Last update: 04:00 PM EST
Day's range
$17.72
Day's range
$18.83

Dianthus Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
FMR LLC 05/12/2025 4.48 M $81.31 M   0.98% 13.09%
RA CAPITAL MANAGEMENT, L.P. 05/15/2025 2.87 M $52.00 M   53.60% 8.37%
FAIRMOUNT FUNDS MANAGEMENT LLC 05/15/2025 2.70 M $48.99 B   0.00% 7.89%
BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC 05/15/2025 2.69 M $48.79 M   0.00% 7.86%
DEEP TRACK CAPITAL, LP 05/15/2025 2.36 M $42.77 M   100.00% 6.89%
OCTAGON CAPITAL ADVISORS LP 05/16/2025 2.34 M $42.48 M   10.97% 6.84%
VR ADVISER, LLC 05/15/2025 1.74 M $31.64 M   0.00% 5.10%
AVIDITY PARTNERS MANAGEMENT LP 05/15/2025 1.72 M $31.22 B   -40.10% 5.03%
VESTAL POINT CAPITAL, LP 05/15/2025 1.70 M $30.84 M   58.15% 4.97%
BLACKROCK, INC. 05/02/2025 1.62 M $29.31 M   -2.13% 4.72%
TCG CROSSOVER MANAGEMENT, LLC 05/14/2025 1.50 M $27.24 M   0.00% 4.39%
POINT72 ASSET MANAGEMENT, L.P. 05/15/2025 1.49 M $26.97 M   668.05% 4.34%
VANGUARD GROUP INC 05/09/2025 1.11 M $20.11 M   -13.00% 3.24%
5AM VENTURE MANAGEMENT, LLC 05/15/2025 1.03 M $18.64 B   0.00% 3.00%
ALLIANCEBERNSTEIN L.P. 05/15/2025 1.03 M $18.60 M   -11.57% 3.00%
05/15/2025 763.47 K $13.85 M   0.00% 2.23%
STATE STREET CORP 05/15/2025 759.68 K $13.78 M   -7.23% 2.22%
JANUS HENDERSON GROUP PLC 05/15/2025 683.62 K $13.70 M   -37.03% 2.00%
GEODE CAPITAL MANAGEMENT, LLC 05/13/2025 517.02 K $9.38 M   6.32% 1.51%
CITADEL ADVISORS LLC 05/15/2025 470.88 K $8.54 M   11.57% 1.38%
BRAIDWELL LP 05/15/2025 375.36 K $6.81 M   -68.89% 1.10%
WOODLINE PARTNERS LP 05/15/2025 300.50 K $5.45 M   0.00% 0.88%
GREAT POINT PARTNERS LLC 05/15/2025 275.00 K $4.99 M   0.00% 0.80%
TANG CAPITAL MANAGEMENT LLC 05/15/2025 264.69 K $4.80 M   0.00% 0.77%
CANDRIAM S.C.A. 05/14/2025 248.61 K $4.51 M   100.00% 0.73%
NORTHERN TRUST CORP 05/13/2025 235.53 K $4.27 M   -4.07% 0.69%
ALPHABET INC. 05/02/2025 208.70 K $3.79 M   0.00% 0.61%
SILVERARC CAPITAL MANAGEMENT, LLC 05/14/2025 190.33 K $3.45 M   100.00% 0.56%
ADAGE CAPITAL PARTNERS GP, L.L.C. 05/15/2025 189.00 K $3.43 M   5.00% 0.55%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/09/2025 168.10 K $3.05 M   0.65% 0.49%
RHENMAN & PARTNERS ASSET MANAGEMENT AB 05/14/2025 126.63 K $2.30 M   11.08% 0.37%
SIO CAPITAL MANAGEMENT, LLC 05/15/2025 117.00 K $2.12 M   100.00% 0.34%
WALLEYE CAPITAL LLC 05/14/2025 106.93 K $1.94 M   29.00% 0.31%
BANK OF AMERICA CORP /DE/ 05/15/2025 93.29 K $1.69 M   19.33% 0.27%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/14/2025 81.60 K $1.48 M   100.00% 0.24%
ALLY BRIDGE GROUP (NY) LLC 05/15/2025 80.58 K $1.46 M   -24.29% 0.24%
MORGAN STANLEY 05/15/2025 79.17 K $1.44 M   -31.78% 0.23%
HUDSON BAY CAPITAL MANAGEMENT LP 05/14/2025 75.00 K $1.36 M   100.00% 0.22%
MOODY ALDRICH PARTNERS LLC 04/29/2025 74.37 K $1.35 M   100.00% 0.22%
BANK OF NEW YORK MELLON CORP 04/29/2025 73.64 K $1.34 M   1.03% 0.22%
GOLDMAN SACHS GROUP INC 05/16/2025 73.43 K $1.33 M   -64.71% 0.21%
WELLINGTON MANAGEMENT GROUP LLP 05/13/2025 67.98 K $1.23 M   12.67% 0.20%
05/12/2025 64.38 K $1.17 M   100.00% 0.19%
AMERICAN CENTURY COMPANIES INC 05/13/2025 47.82 K $867.40 K   8.68% 0.14%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/14/2025 47.38 K $859.44 K   186.76% 0.14%
PNC FINANCIAL SERVICES GROUP, INC. 05/09/2025 37.10 K $672.99 K   0.00% 0.11%
RHUMBLINE ADVISERS 04/08/2025 35.05 K $635.71 K   -2.47% 0.10%
CITIGROUP INC 05/12/2025 34.82 K $631.64 K   14.01% 0.10%
HIGHVISTA STRATEGIES LLC 05/15/2025 31.39 K $569.36 K   0.00% 0.09%
BARCLAYS PLC 05/15/2025 31.14 K $565.00 K   -27.18% 0.09%

Dianthus Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 103 institutional investors and hedge funds held shares of Dianthus Therapeutics, Inc.. The most heavily invested institutionals were:

FMR LLC: 4.48 M

RA CAPITAL MANAGEMENT, L.P.: 2.87 M

Fairmount Funds Management LLC: 2.7 M

Bain Capital Life Sciences Investors, LLC: 2.69 M

Deep Track Capital, LP: 2.36 M

Octagon Capital Advisors LP: 2.34 M

110.16% of Dianthus Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 38.50 M shares in the last 24 months. This purchase volume represents approximately $709.43 M in transactions.